Skip to main content
Premium Trial:

Request an Annual Quote

Billions for Antivirals

The US is investing billions of dollars into antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

The $3.2 billion in funding for the new Antiviral Program for Pandemics comes from the $1.9 trillion American Rescue Plan and could expedite ongoing studies, NBC News adds. The hope, the Journal says, is to develop a Tamiflu-like pill people can take at any initial signs of COVID-19.

"New antivirals that prevent serious COVID-19 illness and death, especially oral drugs that could be taken at home early in the course of disease, would be powerful tools for battling the pandemic and saving lives," Anthony Fauci, chief White House medical advisor and director of the National Institute of Allergy and Infectious Diseases, says according to the Journal, adding that vaccines "remain the centerpiece of our arsenal" fighting the pandemic.

In particular, the program includes $300 million for lab and research support, nearly $1 billion for preclinical and clinical evaluation, about $700 million for development and manufacturing, and $1.2 billion to form collaborative drug discovery groups called Antiviral Drug Discovery Centers for Pathogens of Pandemic Concern to spur antiviral drug discovery and development.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.